Dr Reddy's, Takeda tie up to distribute India's first dengue vaccine QDENGA
Dr Reddy's Laboratories and Takeda Pharmaceutical signed a pact to distribute QDENGA, described as India's first dengue vaccine, in the country. Subject to local regulatory processes, the vaccine is expected to be available in the first half of 2027. The partnership marks a step toward domestic availability of a preventive tool against dengue.
Nabka Insight
India's first dengue vaccine is a high-value health and science-and-tech item.
Powered by AIKey facts
- Dr Reddy's and Takeda signed a pact to distribute QDENGA in India.
- QDENGA is described as India's first dengue vaccine.
- Subject to regulatory clearance, it is expected in the first half of 2027.
Relevant forRailways · SSC · State PSC · UPSC